I spent most of last week trying to figure out who actually makes the starch-based excipient we've been ordering since 2023. My first search was “IFF Chemical Holdings Inc official website.” I got to a site that looked right, clicked around, and found corporate pages about sustainability and customer solutions—but not the pharma product pages I remembered. That was my first clue. The second was the autocomplete suggestion after I typed “IFF completes divestiture pharma solutions news.” A lot of us in procurement were searching for the same clarity at the same time.
Look, I'm not a chemist. I'm an office administrator at a 120-person specialty manufacturing company. I manage purchasing for chemicals, coatings, packaging, and lab supplies—roughly 70 orders a year across 8 vendor relationships, about $1.4 million annually. I report to operations and finance. That means I care about three things: process, compliance, and not looking like a fool when someone asks if a sample arrived.
The reason a big divestiture matters to an administrator like me is simple: companies change, product pages don't, and procurement teams are left to piece together the clues.
The Surface Problem: We Search How We Talk, Not How Suppliers Catalog
Search “all color powder coating” and you'll get a rainbow of options. But few of those links tell you whether the coating is TGIC-free, what the cure temperature is, or whether it's rated for exterior exposure. “Rubberized wood coating” sounds like one product, yet it can mean a flexible deck coating, a wood sealant, or an elastomeric waterproofing paint. If I ordered based on the phrase alone, I would likely order the wrong thing. Honestly, I did order the wrong thing once early on.
A colleague once asked in our internal chat, “where is corn starch in the grocery store?” We were not shopping. We were working on a lab formula. The question made me laugh because it's exactly how we talk about materials: by the aisle we think they live in, not by the chemistry or specification. In B2B, that mismatch has consequences.
When I first started managing chemical purchases in 2020, I assumed the product name on a supplier's website was the product name on the old technical data sheet. That assumption cost me a delayed batch and an uncomfortable conversation with a plant supervisor. Since then, I've learned to translate every fuzzy search term into a set of specifications before I send a request for quote.
The Deeper Problem: Corporate Divestiture Makes Old Labels Even Less Reliable
Now take the IFF pharma solutions divestiture. The products did not disappear. They weren't all renamed overnight. But the legal owner changed, and for buyers, that changes everything.
According to IFF's official press release from February 2024, the sale of its Pharma Solutions business to Roquette closed, making Roquette responsible for that portfolio. If you go to the official IFF website today, you can still find corporate references to the divestiture, but the full technical library for those pharma products may now sit under the new owner's site. That is not a marketing detail. That is a supplier qualification event.
Here is what changed in practical terms:
- The certificate of analysis now comes from a different legal entity.
- The technical support team that answers questions about excipients is no longer IFF's team.
- The labeling and regulatory documentation may carry a different company name in some regions.
- Your approved vendor list, if it still says IFF, may no longer point to the actual manufacturer.
Never expected a corporate divestiture to be a purchasing problem. I thought it was a finance story. Turns out, it is also an inventory story. So glad I checked the news before reordering. Almost sent a purchase order to the old legal entity, which would have created a mess for our accounting team and a delay on the production floor.
The Real Cost of Ignoring This
Let's talk about total cost, because that is how I justify my recommendations to finance. The lowest quoted price for a raw material is rarely the lowest total cost. I learned this during our 2024 vendor consolidation project. We found an alternative excipient that was marginally cheaper per kilogram. It failed a disintegration test. The failed batch cost far more than the raw material savings. We stopped the trial and went back to the original supplier.
There is also regulatory risk. A product from an unapproved owner, or with an outdated certificate of analysis, can hold up an entire batch. In pharma, that is not just a delay; it is an audit issue. Coatings have the same problem in a different way: a color-matched sample without a manufacturer's batch number is not a defensible batch record.
And then there is the internal cost, the one I feel most. When a supplier sends the wrong resin chemistry or misses a lead time, I look bad. That unreliable supplier made me look bad to my VP when materials arrived late. It took three successful orders to rebuild that trust. Not worth the savings.
What I Do Now
Here is the short version, and it is simpler than it sounds. Everything I'd read about vendor consolidation said fewer suppliers is better. In practice, I found that for specialty chemicals and pharma materials, knowing the actual owner matters more than having one master vendor. Consolidation is fine, but only after you verify the legal entity.
- Find the legal owner before you look at price. I still use a search like “IFF Chemical Holdings Inc official website” to get to the corporate pages, but I do not stop there. I look for the latest press release about the business. If a divestiture is mentioned, I trace the product family to the new owner and verify the effective date.
- Translate every fuzzy term into a spec. “All color powder coating” becomes “polyester powder coating, RAL 9016, cure at 180°C for 10 minutes, exterior-grade.” “Rubberized wood coating” becomes “waterborne elastomeric coating for wood, flexible at low temperature, UV-resistant.” “Where is corn starch in the grocery store” becomes “maize starch with a defined particle size, residual protein, and microbial limit.” If I cannot write that spec, I'm not ready to buy.
- Ask for documents before the quote. Certificate of analysis, SDS, technical data sheet, regulatory declaration, country of origin, and a sample. If a supplier cannot provide these quickly, that is a red flag. (Note to self: do not skip the COA step this year.)
- Review your approved vendor list when big news breaks. When a divestiture announcement appears, spend 30 minutes checking your top raw materials. Update vendor codes, contact details, and certificate requirements. I now do this quarterly instead of annually.
Bottom line: a search result is not a supplier qualification document. The logo on an old product page is not a legal ownership statement.
So if you are looking for corn starch in the grocery store, it is usually in the baking aisle. But if you are sourcing excipients after the IFF pharma solutions divestiture, do not look for an aisle. Look for the legal entity, the specification, and the regulatory paperwork. What was best practice in 2020—trusting the product page and the vendor code—may not be enough in 2025. The fundamentals have not changed: know what you are buying, from whom, and under what rules. The execution has changed, though, and that is exactly where procurement teams need to focus.